Search Results
DCGI Approves Phase II, III Clinical Trials Of COVAXIN For The Age Group Of 2 To 18 Years
Covaxin clinical trials for children (2 – 18 years) approved by DCGI
DCGI Approves Covaxin Clinical Trial On 2-18 Year Age Group | OTV News
Bharat Biotech’s 'Covaxin' gets DCGI nod for phase 2, 3 clinical trials on children aged 2 to 18 yrs
Corona Crisis: DCGI approves phase II & III trial of Covaxin for kids
DCGI Approves Phase IIIII Clinical Trial Of Covaxin In 2 To 18 Yrs Age Group
Coronavirus Vaccine News | DCGI Approves Phase 2 And 3 Trials Of Covaxin Of 2-18 Year-Old
Covid-19 Vaccine For Kids | Covaxin Gets Approval For Phase 2-3 Clinical Trials For 2-18 Age Group
DCGI allows Phase II-III clinical trial of Covaxin on 2 to 18-years-old
DCGI approves phase 2, 3 trials of ‘Covaxin’ on 2 to 18 year-olds
DCGI approves trial of COVAXIN for 2 to 18 Years
Clinical trials of Covaxin on children begins